Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00227838 · ClinicalTrials.gov registry record · NA

Modifying Group Therapy for Bipolar Substance Abusers - 1

A NA study, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT00227838 is a NA study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00227838, a NA study, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The purpose of this study is to modify Integrated Group Therapy (IGT), which is has been found successful for patients with bipolar disorder (BD) and substance use disorder(SUD), so that it can be more readily adopted by community drug abuse treatment programs. IGT is being reduced from 20 to 12 sessions in this trial, and is being conducted by front-line drug counselors, to test its effectiveness in a more community-based setting. The training has been expanded so that counselors without much psychopathology training or cognitive behavioral therapy experience can conduct IGT.

Interventions

  • BEHAVIORAL Behavior Therapy

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2003-07
Est. Completion 2005-08
Phase NA

What the Registry Record Tells You About NCT00227838

The ClinicalTrials.gov registry entry for NCT00227838 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Behavior Therapy is the first listed.

NCT00227838 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00227838 about?

NCT00227838 is a clinical study titled "Modifying Group Therapy for Bipolar Substance Abusers - 1". The purpose of this study is to modify Integrated Group Therapy (IGT), which is has been found successful for patients with bipolar disorder (BD) and substance use disorder(SUD), so that it can be more readily adopted by community drug abuse treatment programs. IGT is being reduced from 20 to 12 ses...

What is the current status of trial NCT00227838?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2003-07. Estimated completion is 2005-08.

What interventions are being tested in trial NCT00227838?

The interventions under investigation include: Behavior Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00227838?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.